Search by Drug Name or NDC

    NDC 27854-0103-06 Flanax Pain Reliever 220 mg/1 Details

    Flanax Pain Reliever 220 mg/1

    Flanax Pain Reliever is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Belmora LLC. The primary component is NAPROXEN SODIUM.

    Product Information

    NDC 27854-0103
    Product ID 27854-103_ec7c8e96-24c5-3652-e053-2995a90a196d
    Associated GPIs 66100060100303
    GCN Sequence Number 021980
    GCN Sequence Number Description naproxen sodium TABLET 220 MG ORAL
    HIC3 S2B
    HIC3 Description NSAIDS, CYCLOOXYGENASE INHIBITOR TYPE ANALGESICS
    GCN 47132
    HICL Sequence Number 003726
    HICL Sequence Number Description NAPROXEN SODIUM
    Brand/Generic Generic
    Proprietary Name Flanax Pain Reliever
    Proprietary Name Suffix n/a
    Non-Proprietary Name Naproxen Sodium
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 220
    Active Ingredient Units mg/1
    Substance Name NAPROXEN SODIUM
    Labeler Name Belmora LLC
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA079096
    Listing Certified Through n/a

    Package

    NDC 27854-0103-06 (27854010306)

    NDC Package Code 27854-103-06
    Billing NDC 27854010306
    Package 1 TABLET in 1 POUCH (27854-103-06)
    Marketing Start Date 2008-12-16
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL d5d50bad-9fb2-4575-8ce2-dc8c11c621a2 Details

    Revised: 11/2022